Chemical Compound Review:
Lopac-R-108 (3,4-dihydroxy-5-nitro- phenyl)-(2...
Synonyms:
AC1MRNAO, R108_SIGMA, CHEMBL1256291, SureCN6036458, OR-1139, ...
- In vivo effects of new inhibitors of catechol-O-methyl transferase. Rivas, E., de Ceballos, M.L., Nieto, O., Fontenla, J.A. Br. J. Pharmacol. (1999)
- Catechol-O-methyltransferase inhibition protects against 3,4-dihydroxyphenylalanine (DOPA) toxicity in primary mesencephalic cultures: new insights into levodopa toxicity. Blessing, H., Bareiss, M., Zettlmeisl, H., Schwarz, J., Storch, A. Neurochem. Int. (2003)
- Catechol-O-methyltransferase activity in CHO cells expressing norepinephrine transporter. Percy, E., Kaye, D.M., Lambert, G.W., Gruskin, S., Esler, M.D., Du, X.J. Br. J. Pharmacol. (1999)
- Neurochemical and psychomotor interactions of new selective COMT inhibitors with clorgyline and nomifensine in levodopa-treated rats and mice. Törnwall, M., Tuomainen, P., Männistö, P.T. Archives internationales de pharmacodynamie et de thérapie. (1992)
- Effect of L-Dopa and the catechol-O-methyltransferase inhibitor Ro 41-0960 on sulfur amino acid metabolites in rats. Miller, J.W., Shukitt-Hale, B., Villalobos-Molina, R., Nadeau, M.R., Selhub, J., Joseph, J.A. Clinical neuropharmacology. (1997)
- Phytochemicals inhibit catechol-O-methyltransferase activity in cytosolic fractions from healthy human mammary tissues: implications for catechol estrogen-induced DNA damage. van Duursen, M.B., Sanderson, J.T., de Jong, P.C., Kraaij, M., van den Berg, M. Toxicol. Sci. (2004)